AIM IMMUNOTECH INC. Basic Shares Outstanding (Weighted Average)
AIM IMMUNOTECH INC. (AIM) reported Basic Shares Outstanding (Weighted Average) of 17.12 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- AIM IMMUNOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 17.12M shares, a 2154.57% increase year-over-year.
- AIM IMMUNOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.35M shares, a 518.72% increase year-over-year.
- AIM IMMUNOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.89M shares, a 351.18% increase year-over-year.
- AIM IMMUNOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 2.09M shares, a 262.96% increase year-over-year.
- AIM IMMUNOTECH INC. weighted average number of shares outstanding, basic for fiscal 2025 was 1.62M shares, a 188.95% increase from fiscal 2024.
- AIM IMMUNOTECH INC. weighted average number of shares outstanding, basic for fiscal 2024 was 560.17K shares, a 98.85% decline from fiscal 2023.
- AIM IMMUNOTECH INC. weighted average number of shares outstanding, basic for fiscal 2023 was 48.59M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 17.12M shares 10-Q · filed 2026-08-07 | 10.82M shares 10-Q · filed 2026-08-07 | 8.12M shares derived: average of 3 quarters · filed 2026-08-07 | 6.61M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | 4.35M shares 10-Q · filed 2026-05-15 | 3.62M shares derived: average of 2 quarters · filed 2026-05-15 | 3.11M shares derived: average of 3 quarters · filed 2026-05-15 | 2.52M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | 2.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 2.49M shares derived: average of 2 quarters · filed 2026-03-27 | 1.91M shares derived: average of 3 quarters · filed 2026-08-07 | 1.62M shares 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | 2.09M shares 10-Q · filed 2025-11-17 | 1.43M shares derived: average of 2 quarters · filed 2026-08-07 | 1.20M shares 10-Q · filed 2025-11-17 | 1.05M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | 759.29K shares 10-Q · filed 2026-08-07 | 731.65K shares 10-Q · filed 2026-08-07 | 700.91K shares derived: average of 3 quarters · filed 2026-08-07 | 669.87K shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | 703.30K shares 10-Q · filed 2026-05-15 | 70.33M shares 10-Q · filed 2025-05-15 | 671.72K shares derived: average of 2 quarters · filed 2026-05-15 | 640.07K shares derived: average of 3 quarters · filed 2026-05-15 | 612.14K shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | 640.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 608.45K shares derived: average of 2 quarters · filed 2026-03-27 | 581.76K shares derived: average of 3 quarters · filed 2026-03-27 | 560.17K shares 10-K · filed 2026-03-27 | 56.02M shares 10-K · filed 2025-03-27 | |||
| 2024-09-30 | 576.77K shares 10-Q · filed 2025-11-17 | 57.68M shares 10-Q · filed 2024-11-14 | 552.57K shares derived: average of 2 quarters · filed 2025-11-17 | 533.51K shares 10-Q · filed 2025-11-17 | 53.35M shares 10-Q · filed 2024-11-14 | 24.86M shares derived: average of 4 quarters · filed 2025-11-17 | ||
| 2024-06-30 | 528.37K shares 10-Q · filed 2025-08-14 | 52.84M shares 10-Q · filed 2024-08-14 | 511.62K shares 10-Q · filed 2025-08-14 | 51.16M shares 10-Q · filed 2024-08-14 | 32.96M shares derived: average of 3 quarters · filed 2025-08-14 | 36.88M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 49.46M shares 10-Q · filed 2025-05-15 | 49.17M shares derived: average of 2 quarters · filed 2025-05-15 | 48.99M shares derived: average of 3 quarters · filed 2025-05-15 | 48.85M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 48.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 48.76M shares derived: average of 2 quarters · filed 2025-03-27 | 48.65M shares derived: average of 3 quarters · filed 2025-03-27 | 48.59M shares 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | 48.64M shares 10-Q · filed 2024-11-14 | 48.52M shares derived: average of 2 quarters · filed 2024-11-14 | 48.48M shares 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | 48.41M shares 10-Q · filed 2024-08-14 | 48.41M shares 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 48.40M shares 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |